These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 15085152)

  • 1. Constitutively activated phosphatidylinositol 3-kinase primes platelets from patients with chronic myelogenous leukemia for thrombopoietin-induced aggregation.
    Kubota Y; Tanaka T; Ohnishi H; Kitanaka A; Okutani Y; Taminato T; Ishida T; Kamano H
    Leukemia; 2004 Jun; 18(6):1127-37. PubMed ID: 15085152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of phosphatidylinositol-3 kinase and its association with Gab1 in thrombopoietin-mediated up-regulation of platelet function.
    Kojima H; Shinagawa A; Shimizu S; Kanada H; Hibi M; Hirano T; Nagasawa T
    Exp Hematol; 2001 May; 29(5):616-22. PubMed ID: 11376875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombopoietin complements G(i)- but not G(q)-dependent pathways for integrin {alpha}(IIb){beta}(3) activation and platelet aggregation.
    Campus F; Lova P; Bertoni A; Sinigaglia F; Balduini C; Torti M
    J Biol Chem; 2005 Jul; 280(26):24386-95. PubMed ID: 15863506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crkl is constitutively tyrosine phosphorylated in platelets from chronic myelogenous leukemia patients and inducibly phosphorylated in normal platelets stimulated by thrombopoietin.
    Oda A; Miyakawa Y; Druker BJ; Ishida A; Ozaki K; Ohashi H; Wakui M; Handa M; Watanabe K; Okamoto S; Ikeda Y
    Blood; 1996 Dec; 88(11):4304-13. PubMed ID: 8943867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel thrombopoietin signaling defect in polycythemia vera platelets.
    Moliterno AR; Siebel KE; Sun AY; Hankins WD; Spivak JL
    Stem Cells; 1998; 16 Suppl 2():185-92. PubMed ID: 11012190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphatidylinositol-3 kinase inhibitors reproduce the selective antiproliferative effects of imatinib on chronic myeloid leukaemia progenitor cells.
    Marley SB; Lewis JL; Schneider H; Rudd CE; Gordon MY
    Br J Haematol; 2004 May; 125(4):500-11. PubMed ID: 15142121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HOXA10 expression induced by Abl kinase inhibitors enhanced apoptosis through PI3K pathway in CML cells.
    Sugimoto Y; Nakamura S; Okinaka K; Hirano I; Ono T; Shigeno K; Shinjo K; Ohnishi K
    Leuk Res; 2008 Jun; 32(6):962-71. PubMed ID: 18190961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of platelet activation in vitro by the c-Mpl ligand, thrombopoietin.
    Chen J; Herceg-Harjacek L; Groopman JE; Grabarek J
    Blood; 1995 Dec; 86(11):4054-62. PubMed ID: 7492761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombopoietin modulates platelet activation in vitro through protein-tyrosine phosphorylation.
    Kubota Y; Arai T; Tanaka T; Yamaoka G; Kiuchi H; Kajikawa T; Kawanishi K; Ohnishi H; Yamaguchi M; Takahara J; Irino S
    Stem Cells; 1996 Jul; 14(4):439-44. PubMed ID: 8843545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombopoietin potentiates collagen receptor signaling in platelets through a phosphatidylinositol 3-kinase-dependent pathway.
    Pasquet JM; Gross BS; Gratacap MP; Quek L; Pasquet S; Payrastre B; van Willigen G; Mountford JC; Watson SP
    Blood; 2000 Jun; 95(11):3429-34. PubMed ID: 10828025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in thrombin-induced protein tyrosine phosphorylation of platelets from patients with chronic myelogenous leukemia.
    Shibata K; Nishimura J; Yufu Y; Nawata H
    Int J Hematol; 1992 Apr; 55(2):189-96. PubMed ID: 1387329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombopoietin potentiates the protein-kinase-C-mediated activation of mitogen-activated protein kinase/ERK kinases and extracellular signal-regulated kinases in human platelets.
    Ezumi Y; Uchiyama T; Takayama H
    Eur J Biochem; 1998 Dec; 258(3):976-85. PubMed ID: 9990315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compensatory PI3-kinase/Akt/mTor activation regulates imatinib resistance development.
    Burchert A; Wang Y; Cai D; von Bubnoff N; Paschka P; Müller-Brüsselbach S; Ottmann OG; Duyster J; Hochhaus A; Neubauer A
    Leukemia; 2005 Oct; 19(10):1774-82. PubMed ID: 16136169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombopoietin amplifies ADP-induced HSP27 phosphorylation in human platelets: importance of pre-treatment.
    Cuong NT; Doi T; Matsushima-Nishiwaki R; Akamatsu S; Kuroyanagi G; Kondo A; Mizutani J; Wada I; Otsuka T; Tokuda H; Kozawa O; Ogura S
    Int J Mol Med; 2013 Jun; 31(6):1291-7. PubMed ID: 23588296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A collagen-related peptide regulates phospholipase Cgamma2 via phosphatidylinositol 3-kinase in human platelets.
    Pasquet JM; Bobe R; Gross B; Gratacap MP; Tomlinson MG; Payrastre B; Watson SP
    Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):171-7. PubMed ID: 10432314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purinergic P2Y12 receptor blockade inhibits shear-induced platelet phosphatidylinositol 3-kinase activation.
    Reséndiz JC; Feng S; Ji G; Francis KA; Berndt MC; Kroll MH
    Mol Pharmacol; 2003 Mar; 63(3):639-45. PubMed ID: 12606772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-derived-growth-factor-induced signalling in human platelets: phosphoinositide-3-kinase-dependent inhibition of platelet activation.
    Selheim F; Fukami MH; Holmsen H; Vassbotn FS
    Biochem J; 2000 Sep; 350 Pt 2(Pt 2):469-75. PubMed ID: 10947961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCR-ABL activates STAT3 via JAK and MEK pathways in human cells.
    Coppo P; Flamant S; De Mas V; Jarrier P; Guillier M; Bonnet ML; Lacout C; Guilhot F; Vainchenker W; Turhan AG
    Br J Haematol; 2006 Jul; 134(2):171-9. PubMed ID: 16846476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for phosphatidylinositol 3-kinase in platelet aggregation in response to low, but not high, concentrations of PAF or thrombin.
    Lauener RW; Stevens CM; Sayed MR; Salari H; Duronio V
    Biochim Biophys Acta; 1999 Nov; 1452(2):197-208. PubMed ID: 10559473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera.
    Moliterno AR; Hankins WD; Spivak JL
    N Engl J Med; 1998 Feb; 338(9):572-80. PubMed ID: 9475764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.